Published in Liver Int on February 09, 2009
Heparin-like effect in postcardiotomy extracorporeal membrane oxygenation patients. Crit Care (2014) 0.99
Potential applications of thromboelastography in patients with acute and chronic liver disease. Gastroenterol Hepatol (N Y) (2012) 0.88
Thromboelastographic Evaluation of Dogs with Acute Liver Disease. J Vet Intern Med (2015) 0.78
Coagulopathy and transfusion therapy in pediatric liver transplantation. World J Gastroenterol (2016) 0.75
Early indicators of prognosis in fulminant hepatic failure. Gastroenterology (1989) 7.43
Patients with acute on chronic liver failure display "sepsis-like" immune paralysis. J Hepatol (2005) 2.66
Thrombelastography. Blood Coagul Fibrinolysis (2001) 1.83
Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology (1986) 1.59
Glycosaminoglycans and the regulation of blood coagulation. Biochem J (1993) 1.57
Hepatic response to sepsis: interaction between coagulation and inflammatory processes. Crit Care Med (2001) 1.53
Reversal of post-reperfusion coagulopathy by protamine sulphate in orthotopic liver transplantation. Br J Anaesth (1994) 1.45
Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. J Thromb Haemost (2003) 1.43
Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thrombelastography. J Thromb Haemost (2005) 1.19
New insights into the coagulopathy of liver disease and liver transplantation. World J Gastroenterol (2006) 1.17
Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study. J Hepatol (2002) 1.16
Thrombin generation in patients with cirrhosis: the role of platelets. Hepatology (2006) 1.11
Acute liver failure: current management and future prospects. J Hepatol (2004) 0.96
Extraction of a heparin-like substance from mast cell granules in mouse connective tissue. Nature (1953) 0.95
Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy. Liver Transpl (2003) 0.95
Endogenous heparin-like activity detected by anti-Xa assay in infected cirrhotic and non-cirrhotic patients. Scand J Gastroenterol (2004) 0.94
Deranged blood coagulation equilibrium as a factor of massive liver necrosis following endotoxin administration in partially hepatectomized rats. Hepatology (1999) 0.93
Circulating glycosaminoglycan anticoagulants associated with suramin treatment. Blood (1988) 0.92
The effects of glycosaminoglycans on coagulation: a thromboelastographic study. Blood Coagul Fibrinolysis (2007) 0.92
The management of abnormalities of hemostasis in acute liver failure. Semin Liver Dis (1996) 0.92
Effects of acute liver injury on blood coagulation. J Thromb Haemost (2003) 0.92
Plasma concentrations of endogenous heparinoids in portal hypertension. Gut (1992) 0.85
Adjuvant drugs for end-stage liver failure and transplantation. Med Sci Monit (2004) 0.82
Thromboelastography with heparinase in orthotopic liver transplantation. J Cardiothorac Vasc Anesth (1998) 0.81
Use of heparinase modified thrombelastography in liver transplantation. Br J Anaesth (1997) 0.81
Decreased protein C activation in patients with fulminant hepatic failure. Scand J Gastroenterol (2006) 0.81
New insights into haemostasis in liver failure. Blood Coagul Fibrinolysis (2003) 0.80
Endogenous heparinase-sensitive anticoagulant activity in human plasma. Thromb Res (1992) 0.79
Changes in acidic glycosaminoglycan components at different stages of human liver cirrhosis. Hepatogastroenterology (1984) 0.78
Prothrombin fragment 1 + 2 and thrombin-antithrombin complex measurements indicate continuous and progressive intraoperative thrombin generation in liver transplantation. Haemostasis (1993) 0.77
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med (2011) 15.02
Subcellular localization of the yeast proteome. Genes Dev (2002) 7.93
Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med (2005) 6.31
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol (2008) 5.93
Antibody validation. Biotechniques (2010) 4.42
Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol (2006) 3.65
Post-mortem imaging as an alternative to autopsy in the diagnosis of adult deaths: a validation study. Lancet (2011) 2.66
Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: a multicenter survey on safety and efficacy. Hepatology (2013) 2.64
Transjugular liver biopsy--indications, adequacy, quality of specimens, and complications--a systematic review. J Hepatol (2007) 2.52
Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial. Lancet (2011) 2.50
CT colonography in the detection of colorectal polyps and cancer: systematic review, meta-analysis, and proposed minimum data set for study level reporting. Radiology (2005) 2.48
Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting. BMC Med (2011) 2.44
Hemostasis and thrombosis in patients with liver disease: the ups and downs. J Hepatol (2010) 2.41
EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization. J Hepatol (2011) 2.37
Comparison of the sequential organ failure assessment score with the King's College Hospital criteria and the model for end-stage liver disease score for the prognosis of acetaminophen-induced acute liver failure. Liver Transpl (2012) 2.32
Reporting and methods in clinical prediction research: a systematic review. PLoS Med (2012) 2.26
A comparison between two strategies for monitoring hepatic function during antituberculous therapy. Am J Respir Crit Care Med (2011) 2.22
TIPS for refractory ascites: a single-centre experience. J Gastroenterol (2009) 2.19
Inflammation-based scores do not predict post-transplant recurrence of hepatocellular carcinoma in patients within Milan criteria. Liver Transpl (2014) 2.11
Development of a modified sampling and calculation method for isotope plasma clearance assessment of the glomerular filtration rate in patients with cirrhosis and ascites. Nucl Med Commun (2013) 2.06
Splanchnic vein thrombosis in myeloproliferative neoplasms. Br J Haematol (2013) 2.04
A randomized study comparing ligation with propranolol for primary prophylaxis of variceal bleeding in candidates for liver transplantation. Liver Transpl (2007) 2.01
A population-dynamic model for evaluating the potential spread of drug-resistant influenza virus infections during community-based use of antivirals. J Antimicrob Chemother (2003) 1.92
Different methods of creatinine measurement significantly affect MELD scores. Liver Transpl (2007) 1.87
A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation. Liver Transpl (2006) 1.73
How to prevent varices from bleeding: shades of grey--the case for nonselective beta blockers. Gastroenterology (2007) 1.70
Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study. Liver Transpl (2007) 1.68
Computed tomographic colonography: assessment of radiologist performance with and without computer-aided detection. Gastroenterology (2006) 1.67
Liver transplantation for acute liver failure in Europe: outcomes over 20 years from the ELTR database. J Hepatol (2012) 1.66
Prognostic models in cirrhotics admitted to intensive care units better predict outcome when assessed at 48 h after admission. J Gastroenterol Hepatol (2007) 1.64
Blood CEA levels for detecting recurrent colorectal cancer. Cochrane Database Syst Rev (2015) 1.64
Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis. Hepatology (2011) 1.63
In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis. Am J Pathol (2010) 1.62
Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis? Gut (2011) 1.61
Immunosuppression and donor age with respect to severity of HCV recurrence after liver transplantation. Liver Transpl (2005) 1.58
The relationship between liver disease stage and liver fibrosis: a tangled web. Histopathology (2010) 1.56
Liver transplantation for HBV-related cirrhosis in Europe: an ELTR study on evolution and outcomes. J Hepatol (2012) 1.56
Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy. Liver Transpl (2009) 1.55
Inhibitors of Ras/Raf-1 interaction identified by two-hybrid screening revert Ras-dependent transformation phenotypes in human cancer cells. Proc Natl Acad Sci U S A (2002) 1.52
Resource implications of expanding the use of donation after circulatory determination of death in liver transplantation. Liver Transpl (2012) 1.49
Critical illness-related corticosteroid insufficiency in patients with cirrhosis and variceal bleeding. Clin Gastroenterol Hepatol (2011) 1.49
The typical Cochrane review. How many trials? How many participants? Int J Technol Assess Health Care (2002) 1.45
Hemostasis in patients with acute kidney injury secondary to acute liver failure. Kidney Int (2013) 1.43
No evidence for increased platelet activation in patients with hepatitis B- or C-related cirrhosis and hepatocellular carcinoma. Thromb Res (2014) 1.41
Use of thromboelastography PlateletMapping to monitor antithrombotic therapy in a patient with Budd-Chiari syndrome. Liver Transpl (2010) 1.39
Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses. Cochrane Database Syst Rev (2016) 1.39
Oesophageal perforation complicating intraoperative transoesophageal echocardiography: suspicion can save lives. Interact Cardiovasc Thorac Surg (2010) 1.39
Highly flexible and tough concentric triaxial polystyrene fibers. ACS Appl Mater Interfaces (2014) 1.38
Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study. Curr Med Res Opin (2006) 1.38
Targeting portal pressure measurements: a critical reappraisal. Hepatology (2004) 1.36
Human cytomegalovirus (HCMV) replication dynamics in HCMV-naive and -experienced immunocompromised hosts. J Infect Dis (2002) 1.33
Evaluation of coagulation abnormalities in acute liver failure. J Hepatol (2012) 1.29
Predicting risk of osteoporotic and hip fracture in the United Kingdom: prospective independent and external validation of QFractureScores. BMJ (2011) 1.25
Antibodies against homologous microbial caseinolytic proteases P characterise primary biliary cirrhosis. J Hepatol (2002) 1.24
Liver grafts from anti-hepatitis B core positive donors: a systematic review. J Hepatol (2010) 1.23
Platelet count is not a predictor of the presence or development of gastroesophageal varices in cirrhosis. Hepatology (2008) 1.21
Transfusion triggers in orthotopic liver transplantation: a comparison of the thromboelastometry analyzer, the thromboelastogram, and conventional coagulation tests. J Cardiothorac Vasc Anesth (2006) 1.20
Surgical repair of umbilical hernias in cirrhosis with ascites. Am J Med Sci (2011) 1.17
A systematic review classifies sources of bias and variation in diagnostic test accuracy studies. J Clin Epidemiol (2013) 1.17
Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study. J Hepatol (2002) 1.16
Transarterial therapies for hepatocellular carcinoma (HCC): a long way towards standardization. J Hepatol (2012) 1.15
Methods to decrease blood loss and transfusion requirements for liver transplantation. Cochrane Database Syst Rev (2011) 1.15
Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl (2008) 1.14
Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis. Clin Gastroenterol Hepatol (2009) 1.14
Incremental benefit of computer-aided detection when used as a second and concurrent reader of CT colonographic data: multiobserver study. Radiology (2010) 1.11
New therapeutic paradigm for patients with cirrhosis. Hepatology (2012) 1.10
Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients. Liver Int (2011) 1.10
Immunosuppression and HCV recurrence after liver transplantation. J Hepatol (2011) 1.09
Human papillomavirus testing by self-sampling: assessment of accuracy in an unsupervised clinical setting. J Med Screen (2007) 1.08
RIFLE classification as predictive factor of mortality in patients with cirrhosis admitted to intensive care unit. J Gastroenterol Hepatol (2009) 1.08
Cure of Acanthamoeba cerebral abscess in a liver transplant patient. Liver Transpl (2008) 1.08
Diagnostic accuracy studies: how to report and analyse inconclusive test results. BMJ (2013) 1.08
Impact of primary biliary cirrhosis on perceived quality of life: the UK-PBC national study. Hepatology (2013) 1.07
Measurement of aldehyde dehydrogenase 1 expression defines a group with better prognosis in patients with non-small cell lung cancer. Am J Pathol (2012) 1.06
Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis. J Hepatol (2004) 1.06
Prioritization for liver transplantation. Nat Rev Gastroenterol Hepatol (2010) 1.05
In situ measurement of miR-205 in malignant melanoma tissue supports its role as a tumor suppressor microRNA. Lab Invest (2012) 1.05
Update on the classification, assessment of prognosis and therapy of Budd-Chiari syndrome. Nat Clin Pract Gastroenterol Hepatol (2005) 1.04
Cirrhotics admitted to intensive care unit: the impact of acute renal failure on mortality. Eur J Gastroenterol Hepatol (2009) 1.04
TIPS for acute and chronic Budd-Chiari syndrome: a single-centre experience. J Hepatol (2003) 1.03
Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic. Hepatology (2005) 1.03
Quantifying the effect of antiplatelet therapy: a comparison of the platelet function analyzer (PFA-100) and modified thromboelastography (mTEG) with light transmission platelet aggregometry. Anesthesiology (2006) 1.02
Electrospun PLLA nanofiber scaffolds and their use in combination with BMP-2 for reconstruction of bone defects. PLoS One (2011) 1.00
Standardization of epidermal growth factor receptor (EGFR) measurement by quantitative immunofluorescence and impact on antibody-based mutation detection in non-small cell lung cancer. Am J Pathol (2011) 1.00
Adrenocortical dysfunction in liver disease: a systematic review. Hepatology (2012) 0.99
Management of varices in patients with cirrhosis. Nat Rev Gastroenterol Hepatol (2013) 0.99
Incarcerated umbilical hernia after large volume paracentesis for refractory ascites. J Gastrointestin Liver Dis (2010) 0.99
Assessment of fibrosis and cirrhosis in liver biopsies: an update. Semin Liver Dis (2011) 0.99
Validation of the donor risk index in orthotopic liver transplantation within the Eurotransplant region. Liver Transpl (2012) 0.99
Liver transplantation and recurrent hepatocellular carcinoma: predictive value of nodule size in a retrospective and explant study. Transplantation (2006) 0.98
Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis C. Hepatology (2014) 0.98
Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as a guide for prophylaxis and therapy of bleeding and rebleeding? No. Eur J Intern Med (2010) 0.97
Epithelial colonies cultured from human explanted liver in subacute hepatic failure exhibit hepatocyte, biliary epithelial, and stem cell phenotypic markers. Stem Cells (2003) 0.97
Controlled antibody/(bio-) conjugation of inorganic nanoparticles for targeted delivery. Adv Drug Deliv Rev (2012) 0.96
The role of E. coli infection in the pathogenesis of primary biliary cirrhosis. Dis Markers (2010) 0.96
Biological evaluation of tubulysin A: a potential anticancer and antiangiogenic natural product. Biochem J (2006) 0.96
Quantitative assessment of invasive mena isoforms (Menacalc) as an independent prognostic marker in breast cancer. Breast Cancer Res (2012) 0.96
Liver transplantation for Budd-Chiari syndrome: A European study on 248 patients from 51 centres. J Hepatol (2005) 0.96
Transarterial chemoembolization, transarterial chemotherapy, and intra-arterial chemotherapy for hepatocellular carcinoma treatment. Semin Oncol (2010) 0.95